Richard Close

Stock Analyst at Canaccord Genuity

(1.17)
# 3,768
Out of 5,127 analysts
148
Total ratings
31.03%
Success rate
-14.29%
Average return

Stocks Rated by Richard Close

Doximity
Feb 9, 2026
Upgrades: Buy
Price Target: $48$34
Current: $27.24
Upside: +24.82%
Clover Health Investments
Jan 20, 2026
Maintains: Buy
Price Target: $3.7
Current: $2.13
Upside: +73.71%
HealthStream
Dec 17, 2025
Maintains: Hold
Price Target: $28
Current: $19.97
Upside: +40.21%
Quipt Home Medical
Dec 17, 2025
Maintains: Hold
Price Target: $2.3$3.65
Current: $3.57
Upside: +2.24%
Phreesia
Dec 9, 2025
Maintains: Buy
Price Target: $38$33
Current: $12.41
Upside: +165.91%
Progyny
Nov 17, 2025
Maintains: Hold
Price Target: $23$26
Current: $21.50
Upside: +20.96%
Evolent Health
Nov 14, 2025
Maintains: Buy
Price Target: $16$9
Current: $2.74
Upside: +229.07%
Privia Health Group
Nov 12, 2025
Maintains: Buy
Price Target: $32$34
Current: $21.82
Upside: +55.82%
DocGo
Nov 12, 2025
Maintains: Hold
Price Target: $1.6$1.5
Current: $0.76
Upside: +98.05%
AdaptHealth
Nov 6, 2025
Maintains: Buy
Price Target: $14$15
Current: $10.66
Upside: +40.71%
Maintains: Buy
Price Target: $61$65
Current: $32.97
Upside: +97.15%
Maintains: Buy
Price Target: $5$6
Current: $3.90
Upside: +54.04%
Maintains: Buy
Price Target: $53$54
Current: $23.52
Upside: +129.59%
Maintains: Buy
Price Target: $9$5
Current: $2.05
Upside: +143.90%
Maintains: Buy
Price Target: $27$28
Current: $11.34
Upside: +147.02%
Maintains: Buy
Price Target: $14$12
Current: $4.85
Upside: +147.42%
Initiates: Buy
Price Target: $8
Current: $6.95
Upside: +15.11%
Maintains: Neutral
Price Target: $117$121
Current: $135.49
Upside: -10.69%
Maintains: Buy
Price Target: $22$24
Current: $33.10
Upside: -27.49%
Maintains: Hold
Price Target: $79$95
Current: $79.13
Upside: +20.06%